Amanda Prado1*; William Bigliardi Zibetti2

1Acadêmica do curso de medicina da Universidade Federal de Pelotas
2Médico Residente de Oftalmologia da Universidade Federal de Ciências da Saúde de Porto Alegre.

Introduction: Toxoplasmosis is caused by Toxoplasma gondii, mandatory intracellular protozoan. It’s estimated that one third of the world population is infected with the parasite, a fact that makes it one of the most infectious parasites. Although 80-90% of the immunocompetent infected are asymptomatic, the disease stands out for being one of the main causes of retinochoroiditis, especially among the immunosuppressed.

Case report: Patient, 17 years old, white, female, previously healthy, comes to primary care due to a counter-referral with ophthalmology. Patient presented low visual acuity for 6 months, being diagnosed with ocular toxoplasmosis. Standard treatment was started: sulfadiazine, pyrimethamine, folinic acid and oral prednisolone for 6 weeks. Serum antitoxoplasma titers were obtained indicating previous infection: positive IgG and negative IgM. A patient will face another treatment cycle, as the condition doesn’t improve, which includes high doses of systemic corticosteroids. The physical examination showed no changes. The ophthalmologist requested periodic control of patient’s blood pressure and glucose, extending the treatment.

Conclusion: In immunocompetent individuals, ocular toxoplasmosis is a consequence of reactivation of a scar that contained a previously inactive cyst, only a minority comes from a new infection. It’s considered the most common cause of posterior uveitis, emphasizing the importance of this report. Ocular reactivation occurs due to a decrease in specific immunity and the peak incidence is at 29 years old. Young patients with ocular toxoplasmosis have higher risk of recurrence when compared to elderly. Antitoxoplasma serology isn’t necessary for treatment, which must be started as clinical diagnosis is established.

Keywords:Toxoplasmosis. Ocular toxoplasmosis. Uveitis.

Free Full-text PDF

How to cite this article:
Melo M.I.A, Lapenda N.V.S, Aguiar Y.A, Acioli M.D.To calculate the BMI and measure the AC of a population of a university campus. American Journal of Ophthalmic Research and Reviews, 2018, 1:5. DOI:10.28933/ajoorr-2021-07-0108


1. Saadatnia G, Golkar M. A review on human toxoplasmosis. Scand J Infect Dis. 2012 Nov;44(11):805–14.
2. Bowling B, Kanski JJ. Kanski Oftalmologia Clínica: Uma abordagem sistêmica. Elsevier Brasil; 2016. 928 p.
3. Hosseini SM, Abrishami M, Mehdi Zadeh M. Intravitreal clindamycin in the treatment of unresponsive zone one toxoplasmic chorioretinitis: a case report. Iran Red Crescent Med J. 2014 Nov;16(11):e15428.
4. Garweg JG. Ocular Toxoplasmosis: an Update. Klin Monbl Augenheilkd. 2016 Apr;233(4):534–9.

Terms of Use/Privacy Policy/ Disclaimer/ Other Policies:
You agree that by using our site, you have read, understood, and agreed to be bound by all of our terms of use/privacy policy/ disclaimer/ other policies (click here for details)

CC BY 4.0
This work and its PDF file(s) are licensed under a Creative Commons Attribution 4.0 International License.